Results 61 to 70 of about 7,848 (213)

Three‐Year Outcomes With a Supra‐Annular, Self‐Expanding Bioprosthesis and a Pericardial Wrap—The FORWARD PRO Study

Catheterization and Cardiovascular Interventions, Volume 105, Issue 3, Page 577-587, February 15, 2025.
ABSTRACT Background The self‐expanding, supra‐annular Evolut valve is an established platform for Transcatheter Aortic Valve Implantation (TAVI). Evolut PRO introduced an outer sealing wrap to mitigate paravalvular leakage. We evaluated the 3‐year clinical outcomes and valve performance of the Evolut PRO in standard clinical practice for severe aortic ...
Nicolas M. Van Mieghem, Stephan Windecker, Ganesh Manoharan, Patrizio Lancellotti, Corrado Tamburino, Ran Kornowski, Holger Thiele, Haim Danenberg, Claudia Fiorina, Werner Scholtz, Stephen Brecker, Hendrik Ruge, Anders Opdahl, Giovanni Amoroso, Francesco Bedogni, Anna Sonia Petronio, Georg Nickenig, Axel Harnath, Joerg Kempfert, Jae K. Oh, Ruth E. Eisenberg, Eberhard Grube   +21 more
wiley   +1 more source

Clinical outcomes, hemodynamics, and leaflet thrombosis following transcatheter aortic valve replacement with novel intra‐annular devices

Health Science Reports, Volume 8, Issue 2, February 2025.
Abstract Background The indication of transcatheter aortic valve replacement (TAVR) is becoming more prevalent among younger and lower‐risk patients. However, data on the latest intra‐annular TAVR devices are limited. This study aims to compare the short‐term clinical outcomes of two intra‐annular transcatheter aortic valve replacement (TAVR) devices ...
Juri Iwata, Kentaro Hayashida, Akiyoshi Kajino, Shingo Sakata, Shohei Imaeda, Toshinobu Ryuzaki, Hikaru Tsuruta, Hideyuki Shimizu, Masaki Ieda   +8 more
wiley   +1 more source

Very Early and Unusual Aortic Bioprosthetic Valve Deterioration 9 Months after Implantation

Journal of the Indian Academy of Echocardiography & Cardiovascular Imaging, 2020
Every component of valvular bioprostheses is prone to variable structural deterioration secondary to multifactorial etiopathogenesis. Calcific degeneration is the most common phenomenon.
Madhu Shukla, Vishwas Mohan, Jagdish C. Mohan   +2 more
doaj   +1 more source

Two‐year clinical outcomes of Taiwanese and other Asian ethnicities with atrial fibrillation treated with edoxaban in the ETNA‐AF Asia registry

Journal of Arrhythmia, Volume 41, Issue 1, February 2025.
In this sub‐analysis of the ETNA‐AF registry on Asian patients, the low clinical event rates in two‐year follow‐up reassure the effectiveness and safety of edoxaban in routine care for AF patients in Taiwan, South Korea, Hong Kong, and Thailand. Abstract Background The non‐vitamin K oral anticoagulant (NOAC), edoxaban, is approved for stroke prevention
Chun‐Chieh Wang, Cheng‐I Cheng, Kwo‐Chang Ueng, Wei‐Shiang Lin, Tze‐Fan Chao, Lian‐Yu Lin, Chien‐Lung Huang, Kuan‐Cheng Chang, Guang‐Yuan Mar, Yu‐Cheng Hsieh, Martin Unverdorben, Cathy Chen   +11 more
wiley   +1 more source

Bioprostheses and Mechanical Prostheses for Aortic Valve Replacement in Patients Aged 50 to 65 Years Offer Similar Long-Term Survival Rates

Journal of Cardiovascular Development and Disease
Background: Aortic valve replacement (AVR) is the definitive therapy for patients with severe aortic valve stenosis (AoS). The aim of this work is to compare the effect of a mechanical prosthesis (MP) and a bioprosthesis (BP) on the survival of patients ...
Tomáš Toporcer, Štefan Lukačín, Andrea Kraus, Marián Homola, Anton Bereš, Michal Trebišovský, Denis Radótzy, Vilém Rohn, Adrián Kolesár   +8 more
doaj   +1 more source

Comparison of a novel mechanical valve versus stented bioprosthetic valves for isolated mitral valve replacement in patients older than 65 yearsCentral MessagePerspective

JTCVS Open
Objective: To compare early and long-term clinical outcomes of bioprosthetic versus mechanical (On-X) mitral valve replacement (MVR) in patients aged 65 years and older.
Antonio Piperata, MD, PhD, Carlo Mariani, MD, PhD, Giacomo Murana, MD, PhD, Elio Fabbri, PhD, Paola Rucci, PhD, Maria Francesca Scuppa, MD, Filippo Londi, MD, Edoardo Bianco, MD, Benedetta Guerrini, MD, Ivan Tammaro, MD, Ludovica Fabiani, MD, Margherita Careddu, MD, Marta Bellomare, MD, Silvia Snaidero, MD, Riccardo Nania, MD, Sabrina Castagnini, MD, Marta Di Carlo, MD, Valentina Orioli, MD, Gianluca Folesani, MD, Davide Pacini, MD, PhD   +19 more
doaj   +1 more source

The perceval S aortic valve implantation in patients with porcelain aorta; is this ideal option?

Annals of Cardiac Anaesthesia, 2017
We would like to present in this paper a patient with severe aortic valve stenosis referred to our department for surgical aortic valve replacement. In this patient, it was intraoperatively detected an unexpected heavily calcified porcelain ascending ...
Nikolaos G Baikoussis, Panagiotis Dedeilias, Efstathia Prappa, Michalis Argiriou   +3 more
doaj   +1 more source

Duration of Function of the Porcine Aortic Bioprosthesis in the Aortic Position [PDF]

, 1978
Winston N. Bloch
openalex   +1 more source

Clinical predictors of calcification of xenoaortic biological prosthesis of valves

Acta Biomedica Scientifica, 2014
A retrospective analysis of clinical status of the recipients of biological prosthesis in mitral position was conducted: group 1 included patients with histologically confirmed calcification, group 11 included patients with normal morphology ...
O. K. Kuzmina
doaj  

Neo Left Main Channel Creation Using Double Stenting Alongside a Sapien 3 Aortic Valve Bioprosthesis for Left Main Coronary Obstruction Following Valve-in-Valve Transcatheter Aortic Valve Replacement: A Case Report With Review of Literature

Journal of Investigative Medicine High Impact Case Reports, 2018
Transcatheter aortic valve replacement in the setting of failed surgical bioprosthesis (valve-in-valve) is a valuable option for patients with bioprosthetic aortic stenosis or regurgitation who are deemed high risk for repeat open heart surgery. Although
Apurva D. Patel MD, MPH, Thomas Haldis DO, Kais Al Balbissi MD, Timir Paul MD, PhD   +3 more
doaj   +1 more source